Manual Therapy With Directed Vestibular Rehabilitation in Patients With Unilateral Peripheral Vestibular Hypofunction.

Sponsor
University of Jaén (Other)
Overall Status
Completed
CT.gov ID
NCT04720872
Collaborator
(none)
80
1
2
12.4
6.5

Study Details

Study Description

Brief Summary

Randomized clinical trial with a control group that aims to evaluate the effects of a manual therapy protocol, together with a physical therapist-directed vestibular rehabilitation program, in patients with unilateral peripheral vestibular hypofunction. The intervention period will last approximately 4 weeks. Outcome measures will be collected at baseline, just after the intervention, as well as 1 and 6 months after the intervention.

Condition or Disease Intervention/Treatment Phase
  • Other: Manual therapy and vestibular rehabilitation treatment
N/A

Detailed Description

Peripheral vestibular disorders are common in otorhinolaryngology practice. These patients often complain of vertigo and dizziness, as well as balance problems, causing an important impact on health-related quality of life. The objective of this study was to investigate the effects of manual therapy combined with physical therapist-directed vestibular rehabilitation in patients with unilateral peripheral vestibular hypofunction. The design of this study is a randomized controlled trial with two groups (experimental and control groups). The impact of dizziness on daily function and quality of life (Dizziness Handicap Inventory), the fear of falling and the balance confidence (Activities-specific Balance Confidence scale-16 items), postural control (stabilometric platform) as well as the intensity (visual analogue scale) and number of the vertiginous crisis will be determined. The intervention period will last four weeks. Participants of the experimental group will receive 4 sessions of manual therapy together with physical therapist-directed vestibular rehabilitation, while participants of the control group will receive home-based vestibular rehabilitation. Outcome measurements will take place at baseline, immediately after the intervention, one month and six months after the intervention. Within-group and between-group data will be analyzed and interpreted.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized clinical trialRandomized clinical trial
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
double blind
Primary Purpose:
Treatment
Official Title:
Manual Therapy Combined With Physical Therapist-Directed Vestibular Rehabilitation in Patients With Unilateral Peripheral Vestibular Hypofunction: A Randomized Controlled Trial.
Actual Study Start Date :
Jan 20, 2021
Actual Primary Completion Date :
Oct 31, 2021
Actual Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

Manual therapy: 4 sessions, 1 session per week (20 minutes approximately). Physical therapist-directed vestibular rehabilitation: 4 weeks, 1 session per week with the physical therapist (30 minutes approximately), after manual therapy. Home based vestibular rehabilitation: 4 weeks (2 sessions per day).

Other: Manual therapy and vestibular rehabilitation treatment
The experimental group received manual therapy and vestibular rehabilitation treatment.

No Intervention: Control group

Home based vestibular rehabilitation: 4 weeks (2 sessions per day). The participants attended the center once a week to check correct execution of the exercises.

Outcome Measures

Primary Outcome Measures

  1. Dizziness Handicap Inventory [Baseline-4 weeks]

    Evaluates the level of disability related to the impact of dizziness on daily function and quality of life.

Secondary Outcome Measures

  1. ABC-16 (Activities-specific Balance Confidence scale-16 ítems) [Baseline-4 weeks]

    Questionnaire that assesses balance confidence in performing activities of daily living.

  2. STABILOMETRIC PLATFORM [Baseline-4 weeks]

    Instrument composed of resistive pressure sensors, used to measure the static or postural balance. The test was performed under both eyes-open and eyes-closed conditions.

  3. Visual-Analogue-Scale (VAS) [Baseline-4 weeks]

    The intensity of the vertiginous crisis will be assessed by a visual-analogue-scale during the 4 weeks of the intervention period, respectively.

  4. The number of crisis [Baseline-4 weeks]

    The frequency of the vertiginous crisis will be assessed by the number of crisis during the 4 weeks of the intervention period, respectively.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged ≥ 18 years with a clinical diagnosis of unilateral peripheral vestibular hypofunction confirmed by Video Head Impulse Test (< 0.8), referring balance impairments, postural instability, gait instability, vertigo, dizziness or motion sensitivity, able to understand and complete e instructions, programs, and protocols of this project, and providing a signed informed consent.
Exclusion Criteria:
  • Central nervous system, degenerative or cancer diseases, acute infection.

  • Morphological/ functional alterations of the lower limbs, and/or morphological alteration of the cervical and/or suboccipital rachis.

  • Conditions (i.e. neuromuscular disease or traumatism) that contraindicate the performance of the exercises and interventions of this study, as well as cognitive impairment that prevents the participants from understanding and completing the questionnaires and interventions.

  • Positive results for the Klein test and the Rancurel test, or cerebrovascular alterations.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Complejo Hospitalario Ciudad de Jaén. Av. del Ejército Español, 10, 23007; University of Jaén. Campus Las Lagunillas s/n. 23071 Jaén Spain

Sponsors and Collaborators

  • University of Jaén

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Agustín Aibar Almazán, Principal investigator, University of Jaén
ClinicalTrials.gov Identifier:
NCT04720872
Other Study ID Numbers:
  • University of Jaén.
First Posted:
Jan 22, 2021
Last Update Posted:
Feb 3, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Agustín Aibar Almazán, Principal investigator, University of Jaén
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2022